US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
The products are far from a proven sleep treatment.
Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
Morning Overview on MSN
An experimental drug doubled one-year survival for pancreatic cancer patients
Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...
Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
From Seattle’s first COVID-19 signals to the CDC’s Advisory Committee on Immunization Practices (ACIP), Dr. Helen Chu, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results